Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Schultz

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
NAR Molecular Medicine|September 3, 2025
Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudineHery W Lee, Egor P Tchesnokov, Laura J Stevens, et al.
Nature Medicine|February 17, 2015
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancersBenjamin G Bitler, Katherine M Aird, Azat Garipov, et al.
Molecular Cell|September 27, 2022
The lncRNA ALPHA specifically targets chikungunya virus to control infectionMegha G Basavappa, Max Ferretti, Mark Dittmar, et al.
Molecular Cell|December 18, 2007
PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencingAlexey V Ivanov, Hongzhuang Peng, Vyacheslav Yurchenko, et al.
Molecular Cell|February 19, 2019
Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular SenescencePayel Sen, Yemin Lan, Catherine Y Li, et al.
Cell Reports|April 3, 2021
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Science Immunology|May 19, 2021
Pharmacological activation of STING blocks SARS-CoV-2 infectionMinghua Li, Max Ferretti, Baoling Ying, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Immune history shapes human antibody responses to H5N1 influenza virusesTyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Journal of the National Cancer Institute|February 5, 2015
Adaptive mitochondrial reprogramming and resistance to PI3K therapyJagadish C Ghosh, Markus D Siegelin, Valentina Vaira, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
NAR Molecular Medicine|September 3, 2025
Mechanism and spectrum of inhibition of viral polymerases by 2'-deoxy-2'-β-fluoro-4'-azidocytidine or azvudineHery W Lee, Egor P Tchesnokov, Laura J Stevens, et al.
Nature Medicine|February 17, 2015
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancersBenjamin G Bitler, Katherine M Aird, Azat Garipov, et al.
Molecular Cell|September 27, 2022
The lncRNA ALPHA specifically targets chikungunya virus to control infectionMegha G Basavappa, Max Ferretti, Mark Dittmar, et al.
Molecular Cell|December 18, 2007
PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencingAlexey V Ivanov, Hongzhuang Peng, Vyacheslav Yurchenko, et al.
Molecular Cell|February 19, 2019
Histone Acetyltransferase p300 Induces De Novo Super-Enhancers to Drive Cellular SenescencePayel Sen, Yemin Lan, Catherine Y Li, et al.
Cell Reports|April 3, 2021
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Science Immunology|May 19, 2021
Pharmacological activation of STING blocks SARS-CoV-2 infectionMinghua Li, Max Ferretti, Baoling Ying, et al.
Medrxiv : the Preprint Server for Health Sciences|November 22, 2024
Immune history shapes human antibody responses to H5N1 influenza virusesTyler A Garretson, Jiaojiao Liu, Shuk Hang Li, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2021
Pyrimidine biosynthesis inhibitors synergize with nucleoside analogs to block SARS-CoV-2 infectionDavid C Schultz, Robert M Johnson, Kasirajan Ayyanathan, et al.
Journal of the National Cancer Institute|February 5, 2015
Adaptive mitochondrial reprogramming and resistance to PI3K therapyJagadish C Ghosh, Markus D Siegelin, Valentina Vaira, et al.
Pageof 8